Renal Cancer - Results from #3560

Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. June 19, 2019

Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal masses. June 19, 2019

Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cell Carcinoma June 18, 2019

KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin-1 expression. June 18, 2019

On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis. June 18, 2019

Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literature. June 18, 2019

Recent advances in the systemic treatment of metastatic non-clear cell renal cell carcinomas. June 17, 2019

Immunotherapy for renal cell carcinoma. June 17, 2019

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma. June 17, 2019

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. June 14, 2019

Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma. June 14, 2019

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. June 14, 2019

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. June 13, 2019

Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis. June 13, 2019

Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT. June 13, 2019

Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2. June 12, 2019

UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT. June 12, 2019

Prediction of Significant Estimated Glomerular Filtration Rate Decline Following Renal Unit Removal to Aid in the Clinical Choice between Radical and Partial Nephrectomy in Patients with Renal Mass and Normal Renal Function. June 12, 2019

Association Between Hospitals' Risk-Adjusted Emergency Department Visits and Survival and Costs in Kidney Cancer Patients Undergoing Nephrectomy. June 11, 2019

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma. June 11, 2019

Page 179 of 459